Results 81 to 90 of about 54,104 (311)

Patterns of substrate affinity, competition and degradation kinetics underlie biological activity of thalidomide analogs.

open access: yesBlood, 2019
Pharmacologic agents that modulate ubiquitin ligase activity to induce protein degradation are a major new class of therapeutic agents, active in a number of hematologic malignancies. However, we currently have a limited understanding of the determinants
A. Sperling   +21 more
semanticscholar   +1 more source

Mitigating Teclistamab Toxicity: Prophylactic Tocilizumab and Timing of Immunoglobulin Replacement Therapy in a Nationwide Cohort

open access: yes
American Journal of Hematology, EarlyView.
Astrid Hundebøll Torpe   +14 more
wiley   +1 more source

Structural dynamics of the cereblon ligand binding domain.

open access: yesPLoS ONE, 2015
Cereblon, a primary target of thalidomide and its derivatives, has been characterized structurally from both bacteria and animals. Especially well studied is the thalidomide binding domain, CULT, which shows an invariable structure across different ...
Marcus D Hartmann   +4 more
doaj   +1 more source

Structural basis of thalidomide enantiomer binding to cereblon

open access: yesScientific Reports, 2018
Thalidomide possesses two optical isomers which have been reported to exhibit different pharmacological and toxicological activities. However, the precise mechanism by which the two isomers exert their different activities remains poorly understood. Here,
Tomoyuki Mori   +9 more
semanticscholar   +1 more source

Reducing Exposure Before Birth: An Interrupted Time Series Study of Prenatal Exposure to Fetotoxic Medications Under Risk Management Plans in Canada

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Canada's 2009 risk management plan (RMP) framework has not been evaluated for prenatal exposure impact. Conversely, widely used drugs such as nonsteroidal anti‐inflammatory drugs (NSAIDs) lack RMPs. We assessed first‐trimester exposure to RMP‐regulated medications following regulatory interventions and to NSAIDs following safety publications.
Nahiyan Saiyara Khan   +4 more
wiley   +1 more source

Gut microbiota‐related modulation of immune mechanisms in post‐infarction remodelling and heart failure

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 942-954, April 2025.
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler   +4 more
wiley   +1 more source

Thalidomide ameliorates rosacea-like skin inflammation and suppresses NF-κB activation in keratinocytes.

open access: yesBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019
BACKGROUND Rosacea is a chronic inflammatory skin disorder of uncertain etiology. Evidence suggests the underlying pathogenesis is modulated by abnormal inflammatory and vascular responses.
Mengting Chen   +11 more
semanticscholar   +1 more source

Actions of thalidomide in producing vascular relaxations

open access: yes, 2010
We have investigated the cardiovascular actions of thalidomide in vivo and in vitro. Blood pressure was recorded in pentobarbitone anaesthetized rats. Isometric contractions were examined in rings of rat tail artery and aorta. Radioligand binding studies
James R. Docherty   +7 more
core   +1 more source

Cyclodextrins as Chiral Selectors in Capillary Electrophoresis—Recent Developments in Understanding Analyte Complexation and Applications in Pharmaceutical Analysis

open access: yesELECTROPHORESIS, EarlyView.
Cyclodextrins are the most often applied chiral selectors in CE enantioseparations. In combination with NMR spectroscopy and molecular modeling, studies for an understanding of chiral recognition underlying enantioseparations have been performed.
Gerhard K. E. Scriba
wiley   +1 more source

Crbn I391V is sufficient to confer in vivo sensitivity to thalidomide and its derivatives in mice.

open access: yesBlood, 2018
Thalidomide and its derivatives, lenalidomide and pomalidomide, are clinically effective treatments for multiple myeloma and myelodysplastic syndrome with del(5q).
E. Fink   +31 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy